| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.53B | 9.06B | 8.78B | 8.18B | 7.72B | 7.53B |
| Gross Profit | 656.43M | 396.65M | 575.98M | 482.25M | 412.57M | 278.40M |
| EBITDA | 326.94M | 34.22M | 350.70M | 135.68M | 279.84M | -39.55M |
| Net Income | 51.23M | -274.04M | 72.09M | 105.09M | 122.00M | -184.51M |
Balance Sheet | ||||||
| Total Assets | 8.68B | 8.94B | 8.96B | 8.62B | 8.46B | 8.57B |
| Cash, Cash Equivalents and Short-Term Investments | 1.54B | 1.26B | 1.31B | 1.42B | 1.46B | 1.57B |
| Total Debt | 2.81B | 3.33B | 3.20B | 2.82B | 3.14B | 3.27B |
| Total Liabilities | 6.26B | 6.58B | 6.43B | 6.14B | 6.05B | 6.23B |
| Stockholders Equity | 2.30B | 2.23B | 2.46B | 2.44B | 2.38B | 2.29B |
Cash Flow | ||||||
| Free Cash Flow | 835.03M | 248.92M | -632.71M | -23.20M | -132.14M | 72.16M |
| Operating Cash Flow | 840.48M | 294.67M | -629.01M | -5.52M | -113.96M | 172.49M |
| Investing Cash Flow | 81.75M | 81.52M | 94.67M | 219.25M | 163.54M | 84.06M |
| Financing Cash Flow | -624.61M | -138.23M | 75.14M | -222.40M | -167.90M | 175.59M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$1.18B | 17.57 | 5.24% | 13.24% | 11.24% | 64.66% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | HK$581.26M | 1.65 | 2.37% | ― | -25.78% | -18.64% | |
56 Neutral | HK$412.00M | 10.98 | 9.07% | ― | -16.13% | 5.48% | |
51 Neutral | HK$8.19B | -442.20 | -3.27% | ― | 34.69% | 41.09% | |
48 Neutral | HK$620.00M | -21.69 | -5.86% | 5.26% | -55.42% | -281.93% | |
41 Neutral | HK$792.24M | 3.25 | 2.27% | 1.93% | 0.97% | ― |